Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Ritter Pharmac. Com (RTTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,329
  • Shares Outstanding, K 49,510
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,380 K
  • 36-Month Beta 0.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 14.50
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.42
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/26/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.29 +29.37%
on 12/21/17
0.38 -2.63%
on 01/16/18
+0.07 (+23.33%)
since 12/15/17
3-Month
0.28 +32.14%
on 12/07/17
0.41 -10.84%
on 10/27/17
+0.03 (+7.25%)
since 10/16/17
52-Week
0.28 +32.14%
on 12/07/17
3.75 -90.13%
on 02/06/17
-2.55 (-87.33%)
since 01/13/17

Most Recent Stories

More News
Pre-Market Technical Scan on Biotech Equities -- Ignyta, Pluristem Therapeutics, Ritter Pharma, and Tenax Therapeutics

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on RXDX, PSTI, RTTR, and TENX which can be accessed for free by signing up to www.wallstequities.com/registration....

RTTR : 0.37 (+5.71%)
RXDX : 26.80 (-0.56%)
TENX : 0.37 (-11.69%)
PSTI : 1.59 (-1.24%)
Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, American Superconductor and Stratasys

Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, American Superconductor and Stratasys

AMSC : 5.49 (-0.54%)
RTTR : 0.37 (+5.71%)
BTX : 2.64 (-1.49%)
SSYS : 23.30 (+0.26%)
ONVO : 1.36 (-2.16%)
Try Rising P/E Investing With 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

AMSC : 5.49 (-0.54%)
RTTR : 0.37 (+5.71%)
BTX : 2.64 (-1.49%)
SSYS : 23.30 (+0.26%)
ONVO : 1.36 (-2.16%)
Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, Signal Genetics and Stratasys

Zacks.com highlights: BioTime, Ritter Pharmaceuticals, Organovo Holdings, Signal Genetics and Stratasys

RTTR : 0.37 (+5.71%)
BTX : 2.64 (-1.49%)
MGEN : 8.28 (-7.07%)
SSYS : 23.30 (+0.26%)
ONVO : 1.36 (-2.16%)
Keep Faith in Rising P/E: Play 5 Top-Ranked Stocks

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

RTTR : 0.37 (+5.71%)
BTX : 2.64 (-1.49%)
MGEN : 8.28 (-7.07%)
SSYS : 23.30 (+0.26%)
ONVO : 1.36 (-2.16%)
Ritter Pharmaceuticals Presents at the 10th Annual LD Micro Conference on December 5, 2017

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases,...

RTTR : 0.37 (+5.71%)
Pre-Market Technical Scan on Biotech Equities -- Pluristem Therapeutics, Ritter Pharma, Ignyta, and Tenax Therapeutics

In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued free tailored Stock Review on PSTI, RTTR, RXDX, and TENX which is a click away at www.wallstequities.com/registration....

RTTR : 0.37 (+5.71%)
RXDX : 26.80 (-0.56%)
TENX : 0.37 (-11.69%)
PSTI : 1.59 (-1.24%)
Zacks.com featured highlights: Fortuna Silver Mines, Ritter Pharmaceuticals , Organovo Holdings, Western Digital and Willdan Group

Zacks.com featured highlights: Fortuna Silver Mines, Ritter Pharmaceuticals , Organovo Holdings, Western Digital and Willdan Group

FSM : 5.11 (-3.04%)
RTTR : 0.37 (+5.71%)
WDC : 83.88 (+0.91%)
WLDN : 23.75 (-2.46%)
ONVO : 1.36 (-2.16%)
Take the Less-Trodden Path: Rising P/E for 5 Winning Stocks

Cross the age-old barrier of low P/E investing, bet on these five stocks that boast a rising P/E.

FSM : 5.11 (-3.04%)
RTTR : 0.37 (+5.71%)
WDC : 83.88 (+0.91%)
WLDN : 23.75 (-2.46%)
ONVO : 1.36 (-2.16%)
Ritter Pharmaceuticals Presents at the 5th Microbiome R&D Business Collaboration Forum / 2nd Annual Probiotic Congress

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal...

RTTR : 0.37 (+5.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators are in flux.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance....

See More

Key Turning Points

2nd Resistance Point 0.40
1st Resistance Point 0.39
Last Price 0.37
1st Support Level 0.35
2nd Support Level 0.32

See More

52-Week High 3.75
Fibonacci 61.8% 2.42
Fibonacci 50% 2.02
Fibonacci 38.2% 1.61
Last Price 0.37
52-Week Low 0.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.